For the first 16 weeks, it is taken in smaller doses, and if it is well tolerated, it can be increased to a weekly maintenance dose for as long as needed
Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimotos Thyroiditis
Pancreatitis Inflammation of the pancreas is a severe complication related to GLP-1 medicines
That trajectory is plausible given the mechanistic evidence, though individual responses vary considerably depending on eczema severity, trigger profile, genetic factors, and concurrent treatments
This publication does not independently endorse that specific statistic
Beyond Month 6: Maintenance Most patients continue at 2.4 milligrams weekly through month 12, when full clinical trial endpoints are typically reached